Sudden Hearing Loss
19
4
4
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 19 trials
100.0%
+13.5% vs benchmark
5%
1 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (19)
Trans-round Window Membrane Intracochlear Steroid
Yiyuancong for the Treatment of Sudden Sensorineural Hearing Loss
Study on the Safety and Efficacy of Intratympanic Injection of Small Extracellular Vesicles Derived From Mesenchymal Stem Cells in Severe and Profound Sudden Sensorineural Hearing Loss
Regenerative Medicine and Stem Cell-Based Interventions for Inner Ear Trauma, Tinnitus, and Sensorineural Hearing Loss
Effectiveness of Integrative Medical Treatment in Sudden Hearing Loss
Sudden Sensorineural Hearing Loss in Wonju Severance Christian Hospital
Use of Vibration Anesthesia Device in Intratympanic Injections
Efficacy and Safety of Hydroxychloroquine in the Treatment of Sudden Sensorineural Hearing Loss
FX-322 in Adults With Acquired Sensorineural Hearing Loss
Prognosis of Vestibular Dysfunction in Patients With Idiopathic Sudden Sensorineural Hearing Loss
FX-322 in Adults With Age-Related Sensorineural Hearing Loss
FX-322 in Adults With Severe Sensorineural Hearing Loss
What is the Tympanic Membrane Healing Time After Insertion of a Gelfoam PE Tube?
The Effect of Patient's Position After Intra-tympanic Injection on the Amount of Fluid in the Middle Ear
OSA and Sudden Sensorineural Hearing Loss
The Effect of Patient's Position After Intra-tympanic Injection
The Effect of PAP on ISSHL Comorbided With OSA
Vestibular Prognosis Assessment of ISSNHL With Vestibular Dysfunction Treated With Oral or Intratympanic Glucocorticoids
Ischemia- Modified Albumin Levels in the Sudden Hearing Loss